Cara Therapeutics (CARA) PT Raised to $35 at Needham & Company
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Cara Therapeutics (CARA) FV Target Raised to $33 at Janney
May 29, 2019 3:40 PM EDTJanney analyst Esther Hong raised the fair value target on Cara Therapeutics (NASDAQ: CARA) to $33.00 (from $27.00) while maintaining a Buy rating following data.
The analyst commented, "Today's announcement of positive Ph.3 KALM-1 IV-Korsuva data demonstrating statistical significance on the primary and all... More
Cara Therapeutics (CARA) PT Raised to $33 at Jefferies
May 29, 2019 11:20 AM EDTJefferies analyst Chris Howerton raised the price target on Cara Therapeutics (NASDAQ: CARA) to $33.00 (from $25.00) while maintaining a Buy rating.
... MoreCara Therapeutics (CARA) PT Raised to $28 at H.C. Wainwright
May 29, 2019 10:55 AM EDTH.C. Wainwright analyst Oren Livnat raised the price target on Cara Therapeutics (NASDAQ: CARA) to $28.00 (from $26.00) while maintaining a Buy rating.
... More